Impact of radiotherapy on local control and survival in uterine sarcomas: A retrospective study from the Grup Oncologic Catala-Occita

International Journal of Radiation Oncology Biology Physics

Volumn 44, Issue 1, 1999, Pages 47-52

  Ferrer, Ferran ^a   Sabater, Sebastià ^b   Farrús, Blanca ^a   Guedea, Ferran ^b   Rovirosa, Angels ^a   Anglada, Lluis ^c   Delannes, Martine ^d   Marín, Susanna ^b   Dubois, Jean Bernard ^b   Daly Schveitzer, Nicolas ^d  

^a HOSPITAL CLÍNIC   (Spain)

^b Dept Radiother Hosp S Creu I S ^*  (France)

^c HOSPITAL UNIVERSITARI SANT JOAN DE REUS   (Spain)

^d INSTITUT CLAUDIUS REGAUD   (France)

Author keywords

Loco regional disease free interval; Radiotherapy; Survival; Uterine sarcomas

Indexed keywords

COBALT 60;

ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER INHIBITION; CANCER RADIOTHERAPY; CANCER SURVIVAL; ENDOMETRIUM CARCINOMA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; POSTOPERATIVE CARE; PRIORITY JOURNAL; RADIATION DOSE; UTERUS SARCOMA;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LEIOMYOSARCOMA; MIDDLE AGED; MIXED TUMOR, MULLERIAN; NEOPLASM STAGING; RADIOTHERAPY DOSAGE; RECURRENCE; RETROSPECTIVE STUDIES; SARCOMA; UTERINE NEOPLASMS;

EID: 0033048439     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(98)00515-X     Document Type: Article

References (28)

1. Oláh K.S., Gee H., Blunt S., et al. Retrospective analysis of 318 cases of uterine sarcoma. Eur J Cancer. 27:1991;1095-1099.
2. Salazar O.M., Dunne M.E. The role of radiation therapy in the management of uterine sarcomas. Int J Radiat Oncol Biol Phys. 6:1980;899-902.
3. Kahanpää K.V., Wahlström T., Gröhn P., et al. Sarcoma of the uterus A clinicopathologic study of 119 patients . Obstet Gynecol. 67:1986;417-424.
4. Nordal R.R., Thorensen S.O. Uterine sarcomas in Norway 1956-1992 Incidence, survival and mortality . Eur J Cancer. 33:1997;907-911.
5. Dunton J.C., Kelsten M.L., Brooks S.E., et al. Low-grade stromal sarcoma DNA flow cytometric analysis and estrogen progesterone receptor data . Gynecol Oncol. 37:1990;268-275.
6. Major F.J., Blessing J.A., Silverberg S.G., et al. Prognostic factors in early-stage uterine sarcoma A Gynecologic Oncology Group study . Cancer. 71:(Suppl. 4):1993;1702-1709.
7. Nola M., Babic D., Ilic J., et al. Prognostic parameters for survival patients with malignant mesenchymal tumours of the uterus. Cancer. 78:1996;2543-2550.
8. Perez C., Askin F., Bajlan R.J., et al. Effects of irradiation on mixed Müllerian tumors of the uterus. Cancer. 43:1979;1274-1284.
9. George M., Pejovic M.H., Kramar A. Uterine sarcomas Prognostic factors and treatment modalities-study on 209 patients . Gynecol Oncol. 24:1986;58-67.
10. Salazar O.M., Bonfiglio T.A., Patten S.F., et al. Uterine sarcomas. Analysis of failures with special emphasis on the use of radiation therapy. Cancer. 42:1978;1161-1167.
11. Hoffmann W., Schmandt S., Kortmann R.D., et al. Radiotherapy in the management of uterine sarcomas. A retrospective study of 54 cases. Gynecol Obstet Invest. 42:1996;49-57.
12. Moskovic E., Macsweeney E., Law M., et al. Survival, patterns of spread and prognostic factors in uterine sarcoma A study of 76 patients . Br J Radiol. 66:1993;1009-1013.
13. Kruskal W.H., Wallis W.A. Use of ranks in one criterion variance analysis. J Am Stat Assoc. 47:1952;583-621.
14. Kaplan E.L., Meier P. Nonparametric estimation for incomplete observations. J Am Stat Assoc. 53:1958;457-481.
15. Mantel N., Haenszel W. Chi-square tests with one-degree of freedom extensions of Mantel-Haenszel procedure. J Am Stat Assoc. 58:1963;690-700.
16. Cox D.R. Regression models and life tables. J R Stat Soc. 34:(B):1972;187-220.
17. Hornback N.B., Omura G., Major F.J. Observations on the use of adjuvant radiation therapy in patients with Stage I and II uterine sarcoma. Int J Radiat Oncol Biol Phys. 12:1986;2127-2130.
18. Larson B., Silfverswärd C., Nilsson B., et al. Mixed Müllerian tumours of the uterus-prognostic factors A clinical and histopathologic study of 147 cases . Radiother Oncol. 17:1990;123-132.
19. Valagussa P., Zambetti M., Bonadonna G., et al. Prognostic factors in locally advanced noninflammatory breast cancer. Long-term results following primary chemotherapy. Breast Cancer Res Treat. 15:1990;137-147.
20. Arriagada R., Rutqvist L.A., Mattsson A., et al. Adequate loco-regional treatment for early breast cancer may prevent secondary dissemination. J Clin Oncol. 13:1995;2869-2878.
21. Touboul E., Buffat L., Lefranc J.P., et al. Possibility of conservative local treatment after combined chemotherapy and preoperative irradiation for locally advanced noninflammatory brast cancer. Int J Radiat Oncol Biol Phys. 34:1996;1019-1028.
22. Farrús B., Muñoz M., Bascon N., et al. Impact of loco-regional control on overall survival in non-inflammatory T4 breast cancer treated by triple modality regimen. Cardoso Da Silva J. Breast diseases. 1998;805-809 Monduzzi Editore S, Bologna.
23. Overgaard M., Hansen P.S., Overgaard J., et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. N Engl J Med. 337:1997;949-955.
24. Swedish rectal cancer trial. Coordinators Pahlman L and Glimelius B. Improved survival with preoperative radiotherapy in resectable cancer . N Engl J Med. 336:1997;980-987.
25. Knocke T.H., Kucera H., Dörfler D., et al. The Vienna experience with primary and adjuvant irradiation of sarcoma of the corpus uteri. (Abstr.) Eur J Cancer. 33:(Suppl. 8):1997;207.
26. Oláh K.S., Dunn J.A., Gee H. Leiomyosarcomas have a poorer prognosis than mixed mesodermal tumours when adjusting for known prognostic factors The result of a retrospective study of 423 cases of uterine sarcoma . Br J Obstet Gynaecol. 99:1992;590-594.
27. Sidney S.C. Propensity of retroperitoneal lymph node metastasis in patients with stage I sarcomas of the uterus. Gynecol Oncol. 32:1989;215-217.
28. Wheelock J.B., Krebs H.-B., Scheneider V., et al. Uterine sarcoma Analysis of prognostic variables in 71 cases . Am J Obstet Gynecol. 151:1985;1016-1022.